{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T16:44:26Z","timestamp":1775753066391,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02242-1","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:15:09Z","timestamp":1772622909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Periductal iron-corrected T1 is a predictor of adverse outcomes in large-duct primary sclerosing cholangitis"],"prefix":"10.1186","volume":"26","author":[{"given":"Emmanuel A.","family":"Selvaraj","sequence":"first","affiliation":[]},{"given":"Ahmed","family":"Ba-Ssalamah","sequence":"additional","affiliation":[]},{"given":"Sarah","family":"Poetter-Lang","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Paun","sequence":"additional","affiliation":[]},{"given":"Gerard R.","family":"Ridgway","sequence":"additional","affiliation":[]},{"given":"Cayden","family":"Beyer","sequence":"additional","affiliation":[]},{"given":"Anneli","family":"Andersson","sequence":"additional","affiliation":[]},{"given":"Sir Michael","family":"Brady","sequence":"additional","affiliation":[]},{"given":"Michele","family":"Pansini","sequence":"additional","affiliation":[]},{"given":"Emma L.","family":"Culver","sequence":"additional","affiliation":[]},{"given":"Adam","family":"Bailey","sequence":"additional","affiliation":[]},{"given":"Michael Pavlides","family":"DPhil","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"8","key":"2242_CR1","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","volume":"68","author":"MH Chapman","year":"2019","unstructured":"Chapman MH, Thorburn D, Hirschfield GM, et al. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut. 2019;68(8):1356\u201378. https:\/\/doi.org\/10.1136\/gutjnl-2018-317993.","journal-title":"Gut"},{"issue":"6","key":"2242_CR2","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"TH Karlsen","year":"2017","unstructured":"Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Primary sclerosing cholangitis \u2013 a comprehensive review. J Hepatol. 2017;67(6):1298\u2013323. https:\/\/doi.org\/10.1016\/j.jhep.2017.07.022.","journal-title":"J Hepatol"},{"key":"2242_CR3","doi-asserted-by":"publisher","unstructured":"Pinzani M, Luong TV. Pathogenesis of biliary fibrosis. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2018;1864(4):1279\u20131283. https:\/\/doi.org\/10.1016\/j.bbadis.2017.07.026.","DOI":"10.1016\/j.bbadis.2017.07.026"},{"issue":"6","key":"2242_CR4","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/his.12857","volume":"68","author":"R Colling","year":"2016","unstructured":"Colling R, Verrill C, Fryer E, et al. Bile duct basement membrane thickening in primary sclerosing cholangitis. Histopathology. 2016;68(6):819\u201324. https:\/\/doi.org\/10.1111\/his.12857.","journal-title":"Histopathology"},{"issue":"10","key":"2242_CR5","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/jcp.48.10.933","volume":"48","author":"R Olsson","year":"1995","unstructured":"Olsson R, Hagerstrand I, Broome U, et al. Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis. J Clin Pathol. 1995;48(10):933\u20135. https:\/\/doi.org\/10.1136\/jcp.48.10.933.","journal-title":"J Clin Pathol"},{"issue":"12","key":"2242_CR6","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1007\/s10620-006-9720-1","volume":"52","author":"BD Petrovic","year":"2007","unstructured":"Petrovic BD, Nikolaidis P, Hammond NA, et al. Correlation Between Findings on MRCP and Gadolinium-Enhanced MR of the Liver and a Survival Model for Primary Sclerosing Cholangitis. Dig Dis Sci. 2007;52(12):3499\u2013506. https:\/\/doi.org\/10.1007\/s10620-006-9720-1.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"2242_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00261-016-0847-z","volume":"42","author":"JM Ni Mhuircheartaigh","year":"2017","unstructured":"Ni Mhuircheartaigh JM, Lee KS, Curry MP, Pedrosa I, Mortele KJ. Early Peribiliary Hyperenhancement on MRI in Patients with Primary Sclerosing Cholangitis: Significance and Association with the Mayo Risk Score. Abdom Radiol. 2017;42(1):152\u20138. https:\/\/doi.org\/10.1007\/s00261-016-0847-z.","journal-title":"Abdom Radiol"},{"issue":"12","key":"2242_CR8","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1007\/s00261-018-1590-4","volume":"43","author":"CA Bookwalter","year":"2018","unstructured":"Bookwalter CA, Venkatesh SK, Eaton JE, Smyrk TD, Ehman RL. MR elastography in primary sclerosing cholangitis: correlating liver stiffness with bile duct strictures and parenchymal changes. Abdom Radiol. 2018;43(12):3260\u201370. https:\/\/doi.org\/10.1007\/s00261-018-1590-4.","journal-title":"Abdom Radiol"},{"issue":"3","key":"2242_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00247-025-06173-x","volume":"55","author":"P Debnath","year":"2025","unstructured":"Debnath P, Ata NKA, Cao JY, et al. Magnetic resonance cholangiopancreatography for suspected cholangiopathy in children and young adults: a multi-reader agreement study. Pediatr Radiol. 2025;55(3):479\u201387. https:\/\/doi.org\/10.1007\/s00247-025-06173-x.","journal-title":"Pediatr Radiol"},{"issue":"2","key":"2242_CR10","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00330-021-08147-7","volume":"32","author":"SK Venkatesh","year":"2022","unstructured":"Venkatesh SK, Welle CL, Miller FH, et al. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group. Eur Radiol. 2022;32(2):923\u201337. https:\/\/doi.org\/10.1007\/s00330-021-08147-7.","journal-title":"Eur Radiol"},{"issue":"2","key":"2242_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/apt.14797","volume":"48","author":"R Zenouzi","year":"2018","unstructured":"Zenouzi R, Liwinski T, Yamamura J, et al. Follow-up magnetic resonance imaging\/3D\u2010magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret. Aliment Pharmacol Ther. 2018;48(2):169\u201378. https:\/\/doi.org\/10.1111\/apt.14797.","journal-title":"Aliment Pharmacol Ther"},{"key":"2242_CR12","doi-asserted-by":"publisher","unstructured":"Harisinghani M, Davis T, Ralli G, et al. Accuracy, repeatability, reproducibility and reference ranges of primary sclerosing cholangitis specific biomarkers from quantitative MRCP. Abdom Radiol. Published online April. 2025;17. https:\/\/doi.org\/10.1007\/s00261-025-04941-9.","DOI":"10.1007\/s00261-025-04941-9"},{"issue":"4","key":"2242_CR13","doi-asserted-by":"publisher","first-page":"e0214921","DOI":"10.1371\/journal.pone.0214921","volume":"14","author":"V Bachtiar","year":"2019","unstructured":"Bachtiar V, Kelly MD, Wilman HR, et al. Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver. PLoS ONE. 2019;14(4):e0214921. https:\/\/doi.org\/10.1371\/journal.pone.0214921.","journal-title":"PLoS ONE"},{"issue":"2","key":"2242_CR14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/jmri.25392","volume":"45","author":"EM Tunnicliffe","year":"2017","unstructured":"Tunnicliffe EM, Banerjee R, Pavlides M, Neubauer S, Robson MD. A model for hepatic fibrosis: the competing effects of cell loss and iron on shortened modified Look-Locker inversion recovery T1 (shMOLLI-T1) in the liver. J Magn Reson Imaging. 2017;45(2):450\u201362. https:\/\/doi.org\/10.1002\/jmri.25392.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"2242_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jhep.2013.09.002","volume":"60","author":"R Banerjee","year":"2014","unstructured":"Banerjee R, Pavlides M, Tunnicliffe EM, et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol. 2014;60(1):69\u201377. https:\/\/doi.org\/10.1016\/j.jhep.2013.09.002.","journal-title":"J Hepatol"},{"key":"2242_CR16","doi-asserted-by":"publisher","first-page":"575843","DOI":"10.3389\/fendo.2020.575843","volume":"11","author":"A Dennis","year":"2020","unstructured":"Dennis A, Kelly MD, Fernandes C, et al. Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis. Front Endocrinol (Lausanne). 2020;11:575843. https:\/\/doi.org\/10.3389\/fendo.2020.575843.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2242_CR17","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/liv.13284","volume":"37","author":"M Pavlides","year":"2017","unstructured":"Pavlides M, Banerjee R, Tunnicliffe EM, et al. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity. Liver Int. 2017;37(7):1065\u201373. https:\/\/doi.org\/10.1111\/liv.13284.","journal-title":"Liver Int"},{"issue":"11","key":"2242_CR18","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/j.cgh.2021.09.041","volume":"20","author":"A Andersson","year":"2022","unstructured":"Andersson A, Kelly M, Imajo K, et al. Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis. Clin Gastroenterol Hepatol. 2022;20(11):2451\u2013e24613. https:\/\/doi.org\/10.1016\/j.cgh.2021.09.041.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2242_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/MPG.0000000000002930","volume":"72","author":"K Janowski","year":"2021","unstructured":"Janowski K, Shumbayawonda E, Dennis A, et al. Multiparametric MRI as a Noninvasive Monitoring Tool for Children With Autoimmune Hepatitis. J Pediatr Gastroenterol Nutr. 2021;72(1):108\u201314. https:\/\/doi.org\/10.1097\/MPG.0000000000002930.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"12","key":"2242_CR20","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1111\/liv.14625","volume":"40","author":"ANA Jayaswal","year":"2020","unstructured":"Jayaswal ANA, Levick C, Selvaraj EA, et al. Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver disease. Liver Int. 2020;40(12):3071\u201382. https:\/\/doi.org\/10.1111\/liv.14625.","journal-title":"Liver Int"},{"issue":"5","key":"2242_CR21","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jhep.2023.05.046","volume":"79","author":"A Roca-Fernandez","year":"2023","unstructured":"Roca-Fernandez A, Banerjee R, Thomaides-Brears H, et al. Liver disease is a significant risk factor for cardiovascular outcomes \u2013 A UK Biobank study. J Hepatol. 2023;79(5):1085\u201395. https:\/\/doi.org\/10.1016\/j.jhep.2023.05.046.","journal-title":"J Hepatol"},{"issue":"7","key":"2242_CR22","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1038\/s41591-025-03654-2","volume":"31","author":"E Jackson","year":"2025","unstructured":"Jackson E, Dennis A, Alkhouri N, et al. Cardiac and liver impairment on multiorgan MRI and risk of major adverse cardiovascular and liver events. Nat Med. 2025;31(7):2289\u201396. https:\/\/doi.org\/10.1038\/s41591-025-03654-2.","journal-title":"Nat Med"},{"key":"2242_CR23","doi-asserted-by":"publisher","unstructured":"Andersson A, Loomba R, Beyer C, et al. Change in cT1 following interventions in MASLD: a systematic review and meta-analysis. clinical gastroenterology and hepatology. Published online April. 2025;10. https:\/\/doi.org\/10.1016\/j.cgh.2025.03.003.","DOI":"10.1016\/j.cgh.2025.03.003"},{"issue":"3","key":"2242_CR24","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/jmri.27113","volume":"52","author":"MH Goldfinger","year":"2020","unstructured":"Goldfinger MH, Ridgway GR, Ferreira C, et al. Quantitative MRCP Imaging: Accuracy, Repeatability, Reproducibility, and Cohort-Derived Normative Ranges. Magn Reson Imaging. 2020;52(3):807\u201320. https:\/\/doi.org\/10.1002\/jmri.27113.","journal-title":"Magn Reson Imaging"},{"issue":"4","key":"2242_CR25","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/hep4.1860","volume":"6","author":"EA Selvaraj","year":"2022","unstructured":"Selvaraj EA, Ba-Ssalamah A, Poetter\u2010Lang S, et al. A Quantitative Magnetic Resonance Cholangiopancreatography Metric of Intrahepatic Biliary Dilatation Severity Detects High\u2010Risk Primary Sclerosing Cholangitis. Hepatol Commun. 2022;6(4):795\u2013808. https:\/\/doi.org\/10.1002\/hep4.1860.","journal-title":"Hepatol Commun"},{"issue":"1","key":"2242_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00330-021-08142-y","volume":"32","author":"MF Ismail","year":"2022","unstructured":"Ismail MF, Hirschfield GM, Hansen B, et al. Evaluation of quantitative MRCP (MRCP+) for risk stratification of primary sclerosing cholangitis: comparison with morphological MRCP, MR elastography, and biochemical risk scores. Eur Radiol. 2022;32(1):67\u201377. https:\/\/doi.org\/10.1007\/s00330-021-08142-y.","journal-title":"Eur Radiol"},{"issue":"11","key":"2242_CR27","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/apt.17944","volume":"59","author":"PJ Trivedi","year":"2024","unstructured":"Trivedi PJ, Arndtz K, Abbas N, et al. Quantitative MRCP and metrics of bile duct disease over time in patients with primary sclerosing cholangitis: A prospective study. Aliment Pharmacol Ther. 2024;59(11):1366\u201375. https:\/\/doi.org\/10.1111\/apt.17944.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"2242_CR28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","volume":"77","author":"O Chazouilleres","year":"2022","unstructured":"Chazouilleres O, Beuers U, Bergquist A, et al. EASL Clinical Practice Guidelines on sclerosing cholangitis. J Hepatol. 2022;77(3):761\u2013806. https:\/\/doi.org\/10.1016\/j.jhep.2022.05.011.","journal-title":"J Hepatol"},{"issue":"4","key":"2242_CR29","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1053\/j.gastro.2013.12.030","volume":"146","author":"C Corpechot","year":"2014","unstructured":"Corpechot C, Gaouar F, El Naggar A, et al. Baseline Values and Changes in Liver Stiffness Measured by Transient Elastography Are Associated With Severity of Fibrosis and Outcomes of Patients With Primary Sclerosing Cholangitis. Gastroenterology. 2014;146(4):970\u2013e9796. https:\/\/doi.org\/10.1053\/j.gastro.2013.12.030.","journal-title":"Gastroenterology"},{"issue":"10","key":"2242_CR30","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1111\/liv.13402","volume":"37","author":"EMG De Vries","year":"2017","unstructured":"De Vries EMG, F\u00e4rkkil\u00e4 M, Milkiewicz P, et al. Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi\u2010centre study. Liver Int. 2017;37(10):1554\u201361. https:\/\/doi.org\/10.1111\/liv.13402.","journal-title":"Liver Int"},{"issue":"10","key":"2242_CR31","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1136\/gutjnl-2016-313681","volume":"67","author":"EM De Vries","year":"2018","unstructured":"De Vries EM, Wang J, Williamson KD, et al. A novel prognostic model for transplant-free survival in primary sclerosing cholangitis. Gut. 2018;67(10):1864\u20139. https:\/\/doi.org\/10.1136\/gutjnl-2016-313681.","journal-title":"Gut"},{"issue":"5","key":"2242_CR32","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jhep.2019.06.012","volume":"71","author":"JC Goet","year":"2019","unstructured":"Goet JC, Floreani A, Verhelst X, et al. Validation, clinical utility and limitations of the Amsterdam-Oxford model for primary sclerosing cholangitis. J Hepatol. 2019;71(5):992\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2019.06.012.","journal-title":"J Hepatol"},{"key":"2242_CR33","doi-asserted-by":"publisher","unstructured":"Kim WR, Therneau TM, Wiesner RH et al. A revised natural history model for primary sclerosing cholangitis. Mayo Clinic Proceedings. 2000;75(7):688\u2013694. https:\/\/doi.org\/10.4065\/75.7.688.","DOI":"10.4065\/75.7.688"},{"issue":"7","key":"2242_CR34","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1007\/s00330-020-06728-6","volume":"30","author":"M Tafur","year":"2020","unstructured":"Tafur M, Cheung A, Menezes RJ, et al. Risk stratification in primary sclerosing cholangitis: comparison of biliary stricture severity on MRCP versus liver stiffness by MR elastography and vibration-controlled transient elastography. Eur Radiol. 2020;30(7):3735\u201347. https:\/\/doi.org\/10.1007\/s00330-020-06728-6.","journal-title":"Eur Radiol"},{"issue":"2","key":"2242_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jhep.2012.10.013","volume":"58","author":"S Al Mamari","year":"2013","unstructured":"Al Mamari S, Djordjevic J, Halliday JS, Chapman RW. Improvement of serum alkaline phosphatase to <\u20091.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol. 2013;58(2):329\u201334. https:\/\/doi.org\/10.1016\/j.jhep.2012.10.013.","journal-title":"J Hepatol"},{"issue":"5","key":"2242_CR36","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/hep.30479","volume":"69","author":"EC Goode","year":"2019","unstructured":"Goode EC, Clark AB, Mells GF, et al. Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System. Hepatology. 2019;69(5):2120\u201335. https:\/\/doi.org\/10.1002\/hep.30479.","journal-title":"Hepatology"},{"issue":"1","key":"2242_CR37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/hep.26620","volume":"59","author":"A Ruiz","year":"2014","unstructured":"Ruiz A, Lemoinne S, Carrat F, Corpechot C, Chazouill\u00e8res O, Arriv\u00e9 L. Radiologic course of primary sclerosing cholangitis: Assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression. Hepatology. 2014;59(1):242\u201350. https:\/\/doi.org\/10.1002\/hep.26620.","journal-title":"Hepatology"},{"issue":"13","key":"2242_CR38","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1016\/j.cgh.2019.03.013","volume":"17","author":"S Lemoinne","year":"2019","unstructured":"Lemoinne S, Cazzagon N, El Mouhadi S, et al. Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis. Clin Gastroenterol Hepatol. 2019;17(13):2785\u2013e27923. https:\/\/doi.org\/10.1016\/j.cgh.2019.03.013.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"2242_CR39","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1136\/gut.51.4.562","volume":"51","author":"CY Ponsioen","year":"2002","unstructured":"Ponsioen CY. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut. 2002;51(4):562\u20136. https:\/\/doi.org\/10.1136\/gut.51.4.562.","journal-title":"Gut"},{"issue":"09","key":"2242_CR40","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1055\/s-0030-1255527","volume":"42","author":"C Ponsioen","year":"2010","unstructured":"Ponsioen C, Reitsma J, Boberg K, Aabakken L, Rauws E, Schrumpf E. Validation of a cholangiographic prognostic model in primary sclerosing cholangitis. Endoscopy. 2010;42(09):742\u20137. https:\/\/doi.org\/10.1055\/s-0030-1255527.","journal-title":"Endoscopy"},{"issue":"12","key":"2242_CR41","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1111\/liv.13899","volume":"38","author":"A Tenca","year":"2018","unstructured":"Tenca A, Mustonen H, Lind K, et al. The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis. Liver Int. 2018;38(12):2329\u201339. https:\/\/doi.org\/10.1111\/liv.13899.","journal-title":"Liver Int"},{"issue":"9","key":"2242_CR42","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/MEG.0b013e3283554bbf","volume":"24","author":"MH Chapman","year":"2012","unstructured":"Chapman MH, Webster GJM, Bannoo S, Johnson GJ, Wittmann J, Pereira SP. Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience. European J Gastroenterology Hepatology. 2012;24(9):1051\u20138. https:\/\/doi.org\/10.1097\/MEG.0b013e3283554bbf.","journal-title":"European J Gastroenterology Hepatology"},{"issue":"1","key":"2242_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00261-018-1701-2","volume":"44","author":"A Mojtahed","year":"2019","unstructured":"Mojtahed A, Kelly CJ, Herlihy AH, et al. Reference range of liver corrected T1 values in a population at low risk for fatty liver disease-a UK Biobank sub-study, with an appendix of interesting cases. Abdom Radiol (NY). 2019;44(1):72\u201384. https:\/\/doi.org\/10.1007\/s00261-018-1701-2.","journal-title":"Abdom Radiol (NY)"},{"key":"2242_CR44","doi-asserted-by":"publisher","unstructured":"Heneghan MA, Shumbayawonda E, Dennis A, et al. Quantitative magnetic resonance imaging to aid clinical decision making in autoimmune hepatitis. eClinicalMedicine. 2022;46. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101325.","DOI":"10.1016\/j.eclinm.2022.101325"},{"issue":"2","key":"2242_CR45","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s00261-021-03378-0","volume":"47","author":"N Mahalingam","year":"2022","unstructured":"Mahalingam N, Trout AT, Gandhi DB, et al. Associations between MRI T1 mapping, liver stiffness, quantitative MRCP, and laboratory biomarkers in children and young adults with autoimmune liver disease. Abdom Radiol. 2022;47(2):672\u201383. https:\/\/doi.org\/10.1007\/s00261-021-03378-0.","journal-title":"Abdom Radiol"},{"issue":"6","key":"2242_CR46","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2214\/AJR.22.28765","volume":"220","author":"AT Trout","year":"2023","unstructured":"Trout AT, Taylor AE, Kasten JL, et al. Corrected T1 Mapping in Children and Young Adults With Autoimmune Liver Disease: Correlation With Histology. Am J Roentgenol. 2023;220(6):901\u20132. https:\/\/doi.org\/10.2214\/AJR.22.28765.","journal-title":"Am J Roentgenol"},{"issue":"11","key":"2242_CR47","doi-asserted-by":"publisher","first-page":"100577","DOI":"10.1016\/j.jhepr.2022.100577","volume":"4","author":"N Cazzagon","year":"2022","unstructured":"Cazzagon N, El Mouhadi S, Vanderbecq Q, et al. Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis. JHEP Rep. 2022;4(11):100577. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100577.","journal-title":"JHEP Rep"},{"issue":"10","key":"2242_CR48","doi-asserted-by":"publisher","first-page":"100834","DOI":"10.1016\/j.jhepr.2023.100834","volume":"5","author":"R Vuppalanchi","year":"2023","unstructured":"Vuppalanchi R, Are V, Telford A, et al. A composite score using quantitative magnetic resonance cholangiopancreatography predicts clinical outcomes in primary sclerosing cholangitis. JHEP Rep. 2023;5(10):100834. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100834.","journal-title":"JHEP Rep"},{"issue":"3","key":"2242_CR49","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.dld.2022.10.015","volume":"55","author":"L Cristoferi","year":"2023","unstructured":"Cristoferi L, Porta M, Bernasconi DP, et al. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis. Dig Liver Disease. 2023;55(3):373\u201380. https:\/\/doi.org\/10.1016\/j.dld.2022.10.015.","journal-title":"Dig Liver Disease"},{"issue":"6","key":"2242_CR50","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s00261-022-03733-9","volume":"48","author":"N Mahalingam","year":"2023","unstructured":"Mahalingam N, Trout AT, Zhang B, Castro-Rojas C, Miethke AG, Dillman JR. Longitudinal changes in quantitative magnetic resonance imaging metrics in children and young adults with autoimmune liver disease. Abdom Radiol. 2023;48(6):1933\u201344. https:\/\/doi.org\/10.1007\/s00261-022-03733-9.","journal-title":"Abdom Radiol"},{"key":"2242_CR51","doi-asserted-by":"publisher","first-page":"109101","DOI":"10.1016\/j.ejrad.2020.109101","volume":"129","author":"KI Ringe","year":"2020","unstructured":"Ringe KI, Bergquist A, Lenzen H, et al. Clinical features and MRI progression of small duct primary sclerosing cholangitis (PSC). Eur J Radiol. 2020;129:109101. https:\/\/doi.org\/10.1016\/j.ejrad.2020.109101.","journal-title":"Eur J Radiol"},{"issue":"4","key":"2242_CR52","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","volume":"134","author":"E Bj\u00f6rnsson","year":"2008","unstructured":"Bj\u00f6rnsson E, Olsson R, Bergquist A, et al. The Natural History of Small-Duct Primary Sclerosing Cholangitis. Gastroenterology. 2008;134(4):975\u201380. https:\/\/doi.org\/10.1053\/j.gastro.2008.01.042.","journal-title":"Gastroenterology"},{"issue":"8","key":"2242_CR53","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1007\/s00261-020-02572-w","volume":"45","author":"K Kozaka","year":"2020","unstructured":"Kozaka K, Sheedy SP, Eaton JE, Venkatesh SK, Heiken JP. Magnetic resonance imaging features of small-duct primary sclerosing cholangitis. Abdom Radiol. 2020;45(8):2388\u201399. https:\/\/doi.org\/10.1007\/s00261-020-02572-w.","journal-title":"Abdom Radiol"},{"issue":"6","key":"2242_CR54","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/(SICI)1097-0029(19970915)38:6<552::AID-JEMT2>3.0.CO;2-H","volume":"38","author":"Y Nakanuma","year":"1997","unstructured":"Nakanuma Y, Hoso M, Sanzen T, Sasaki M. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microsc Res Tech. 1997;38(6):552\u201370. 10.1002\/. (SICI)1097-0029(19970915)38:6%3C552::AID-JEMT2%3E3.0.CO;2-H.","journal-title":"Microsc Res Tech"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02242-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02242-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02242-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T15:45:13Z","timestamp":1775749513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02242-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2242"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02242-1","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and the principles of good clinical practice. All participants provided written informed consent. Ethical approval was granted by the National Research Ethics Service, and by the local Research and Development Department at Oxford University Hospitals National Health Service Foundation Trust.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M.Pav. M.B. and G.R. are shareholders in Perspectum Ltd. B.P., C.B., A.A. and M.Pans. are employees of Perspectum Ltd. A.B.S. receives consulting fees from Bayer and honoraria for lectures from Novartis, Siemens, Bayer, and Sanofi. E.A.S., A.B., S.P.L. and E.L.C. have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}